100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2003 Research Grants

Dana-Farber Cancer Institute
Nabeel  Bardeesy, Ph.D.
Pancreatic Cancer Models for The Identification of Biomarkers and Tumor Maintenance Programs

Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Hedgehog Inhibitors of Pancreatic Cancer

Mayo Clinic College of Medicine
Janet Olsen, Ph.D.
Identification of Early Stage Pancreatic Cancer Biomarkers using LC-Dual ESI-FT-ICR Mass Spectrometry

Mayo Clinic at Rochester
Suresh T. Chari, M.D.
Serum Proteomics of Pancreatic Cancer- Induced Diabetes
Meharry Medical College and Vanderbilt University
Ana M. Grau, M.D.
Role of Rhob in Tumorigenesis and Metastasis In Pancreatic Cancer

Memorial Sloan-Kettering Cancer Center
Richard N. Kolesnick, M.D.
Development of KSR Phosphorothioate Antisense Oligonucleotides in the Treatment of Human Pancreatic Cancer

Mt. Sinai Hospital, Toronto / Samuel Lunenfeld Research Institute
Steven  Gallinger, M.D.
A Novel Pancreatic Cancer Tumor Suppressor Candidate Gene

New York University School of Medicine
Daniel  Meruelo, Ph.D.
Imaging-Assisted Design of Viral Vectors to Eradicate Metastatic Pancreatic Cancer

Northwestern University
Paul Grippo, Ph.D.
Dual Targeting of Mutant Kras And Muchin1 in Mice That Develop Human Like Panins

Stanford University School of Medicine
Jonathan  Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes with DNA Microarrays

State University of New York at Stony Brook
Dafna  Bar-Sagi, Ph.D.
Analysis of Pancreatic Ductal Adenocarcinoma Progression in a Mouse Model of Hereditary Pancreatitis

University of Alabama at Birmingham
Pierre L. Triozzi, M.D.
ErbB Receptor Immunotherapy

University of California at San Francisco
Matthias  Hebrok, Ph.D.
Embryonic Signaling Pathways in Pancreatic Cancer

University of Michigan Medical Center
Diane M. Simeone, M.D.
Development and Validation of Novel Biomarkers for Early Pancreatic Cancer Detection

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303